(18)F-florbetaben Aβ imaging in mild cognitive impairment.
Le 02 Nov 2021
Auteur : Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chételat G, Raniga P, Mulligan RS, Salvado O, Putz B, Roth K, Masters CL, Reininger CB, Rowe CC
Année : 2013
Journal : Alzheimers Res Ther 1758-9193
PubMed Id : 23324163
(18)F-florbetaben and positron emission tomography were used to examine the relationships between β-amyloid (Aβ) deposition, cognition, hippocampal volume, and white matter hyperintensities in mild cognitive impairment (MCI).
